Journal of vascular surgery cases and innovative techniques
August 23, 2026 · via Europe PMC
An oval-shaped arteriotomy for radiocephalic arteriovenous fistula creation: A retrospective cohort study.
Al-Hakkak SMM, Al-Faham FSM.
AI summary — for doctors, generated from the abstract only
An oval-shaped arteriotomy for radiocephalic fistula creation achieved 94% primary patency at 6 months in this retrospective cohort.
What was studied
Retrospective cohort of 104 end-stage renal disease patients from October 2023 to December 2024.
Key findings
- Primary patency at 6 months was 94% and 90% matured within 4 to 6 weeks.
- Early thrombosis in 4% and hematoma requiring evacuation in 2%.
- No infections, steal or aneurysms; median operative time 42 minutes.
Clinical relevance
Fistula maturation is a major challenge, and a simple technical tweak might help.
Who should care
Limitations
Uncontrolled single-series with short follow-up, so superiority over standard arteriotomy is untested.
The technique seems feasible; wait for comparative trials before changing practice.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
The oval-shaped arteriotomy technique for radiocephalic arteriovenous fistula creation was evaluated in 104 patients with end-stage renal disease from October 2023 to December 2024. Ninety-four percent had primary patency at 6 months, and 90% had maturation within 4 to 6 weeks. Early thrombosis was seen in 4%, and hematoma requiring evacuation was seen in 2%. There were no infections, steal syndrome, or aneurysmal changes. The median operative time was 42 minutes. The oval-shaped arteriotomy technique was shown to be technically feasible and effective and deserves to be compared in trials to confirm its value.
DOI
10.1016/j.jvscit.2026.102466
PMID
42824874
PMCID
PMC13628233
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed